How has Medifast's investment income, amortization of discount changed year-over-year?

Medifast's investment income, amortization of discount decreased by 13.7% year-over-year, from $190K to $164K.

Medifast MED Investment Income, Amortization of Discount

Investment Income, Amortization of Discount at other companies

Apogee Therapeutics, Inc.APGE

$1.55M-34.9%

Denali Therapeutics Inc.DNLI

$1.26M-67.6%

Palladyne AI Corp.PDYN

$239K-6.3%

Alignment HealthcareALHC

$245K-33.8%

AsanaASAN

$255K-65.4%

CevaCEVA

$104K-58.2%

Other financials

Income statement

See full

Revenue$76.0M-34.3%

Gross profit$51.8M-38.6%

Operating income-$3.3M-161%

Net income-$2.1M-175%

EPS (diluted)-$0.19-171%

Balance sheet

See full

Cash & equivalents$71.5M-22.0%

Total debt$16.1M+10.2%

Total equity$197.7M-6.3%

Total assets$252.0M-10.0%

Cash flow

See full

Operating cash flow$260.0K-92.4%

CapEx$1.1M-28.0%

Free cash flow-$836.0K-144%

Valuation

See full

Market cap$121.87M-17.4%

Enterprise value$66.44M+12.8%

P/S0.4×0.0×

Profitability

See full

Gross margin70.1%-3.8pp

Operating margin-4.7%-7.0pp

Net margin-5.8%-8.1pp

FCF margin5%-9.3pp

Returns & leverage

See full

Return on equity-9.8%-20.1pp

Debt / equity0.1×0.0×

Current ratio4.8×+1.3×

Where this comes from

Reported directly by Medifast in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeAmortizationOfDiscount.

The official record: Medifast’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medifast's investment income, amortization of discount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Medifast's investment income, amortization of discount?: Medifast (MED) reported investment income, amortization of discount of $164K in Q1 2026.
How has Medifast's investment income, amortization of discount changed year-over-year?: Medifast's investment income, amortization of discount decreased by 13.7% year-over-year, from $190K to $164K.